Approved Respiratory Care Certificate Program
review the following information and then login to the activity.
Date: December 18, 2007
Expiration Date: December 18, 2010
is a leader in educating community pharmacists on how to develop patient
care niches focused on disease management and wellness. This program will
provide participants with 6 modules and a pharmacist tool kit totaling
15 ACPE continuing education contact hours (1.5 CEUs) in pharmacy education.
For a complete listing of NCPA educational programs, refer to www.ncpanet.org.
pharmacists are in an ideal position to identify patients with respiratory
diseases or help manage patients who have already been diagnosed with
Asthma or Chronic Obstructive Pulmonary Disease (COPD). This Respiratory
Care Certificate Program provides practical information community pharmacists
need on screening and managing patients with respiratory conditions through
reviewing patient prescription records, screening, and counseling patients
on medications, lifestyle issues and device usage.
20.5 million people in the U.S. have been diagnosed with Asthma with 9
million of those diagnoses in children under 18 years of age. Asthma results
in 12.7 million physician office visits and 500,000 hospitalizations as
well as 2 million Asthma related emergency room visits yearly. The cost
to society is 16.1 billion dollars. COPD is the 4th leading cause of death
in the U.S. and although estimates are that 30 million people have COPD,
only 16 million of those have been diagnosed and are undergoing treatment.
5% of all physician visits in the U.S. are related to COPD and 15% of
all hospitalizations are a result of COPD. The direct and indirect costs
to society of COPD are $37.2 billion.
A patient care niche focused on respiratory care can be professionally
rewarding for pharmacists and add significantly to the quality of life
of patients. Learn the ins and outs of establishing a successful niche
focused on respiratory care.
At the conclusion
of this program, participants should be able to:
and describe the pathophysiology and prevalance of Asthma and Chronic
Obstructive Pulmonary Disease (COPD)
primary goals for management of Asthma
individualized trigger avoidance plans for patients
the role and value of the various pharmacotherapeutic choices to treat
Asthma and COPD, including mechanisms of action, dosing, administration,
adverse effects and precautions
considerations for the management of asthma in special populations
specific services pharmacists can provide to patients with asthma or
Medicare Medication Therapy Management and the implications for respiratory
a business plan for a respiratory management program
National Community Pharmacists Association (NCPA) is approved by the Accreditation
Council for Pharmacy Education (ACPE) as an approved provider of general
pharmacy education and certificate programs. This online home study program
consists of 15 contact hours (1.5 CEUs) of continuing education (CE) credit.
This program is no longer valid after December 18, 2010. This education
program is a publication of NCPA.
Universal Program Number
1: Pathophysiology and Clinical Features of Asthma
2: Treatment of Asthma
3: Medication Administration and Patient Monitoring
4: Special Populations
5: Chronic Obstructive Pulmonary Disease (COPD)
6: Pharmacy Based Respiratory Therapy Services
Geneva Clark Briggs, Pharm.D., BCPS
Scott K. Stolte, Pharm.D.
Stacey M. Swartz, Pharm. D.
To receive continuing education credit you must review the full content
of each module and successfully complete the post-test following each
module. This program contains 6 modules and 6 post-tests. You must receive
a grade of 70% or higher to pass each post-test. Your statement of credit
will be issued electronically and immediately upon successful completion
of each post-test and submission of the evaluation. A Certificate of Achievement
will also be issued electronically immediately upon successful completion
of all post-tests.
Fee: There is no fee associated with this activity.
This professional education program is supported through an educational
program grant from Merck & Co., Inc.
It is the policy of NCPA® for individuals who are in a position to
control the content of an educational activity to disclose to the learners
all relevant financial relationships that they have with any commercial
interest(s) that provide products or services that may be relevant to
the content of this continuing medical educational activity.
NCPA has no relevant financial relationship with any commercial interests
related directly or indirectly to the content of this educational activity.
Geneva Briggs discloses that she has no relevant financial relationship
with the program sponsor.
Scott Stolte discloses that he has no relevant financial relationship
with the program sponsor.